超过50 mm的出血性卵巢囊肿:超声专家评估的价值
回顾性分析同一机构绝经前女性经阴道盆腔超声报告中最大径超过50 mm、标注为可能出血性卵巢囊肿的附件肿块,由4名超声专家进行两项评估。结果显示,专家评估为典型出血性卵巢囊肿或子宫内膜瘤时,肿瘤和恶性肿瘤比例显著降低(p<.001),超过10%的肿块为肿瘤(近2%为恶性)。
要点
- 超过50 mm的附件肿块标注为可能出血性卵巢囊肿时,专家评估可降低肿瘤和恶性肿瘤的漏诊风险。
- 专家评估符合典型出血性卵巢囊肿(除大小外)时,94.7%的病例最终为出血性卵巢囊肿。
- 专家评估不符合时,68.8%为良性肿瘤,10.4%为交界性肿瘤,4.2%为高级别恶性肿瘤。
核心结论
- 超声专家对标注为可能大出血性卵巢囊肿的附件肿块进行复核评估有附加价值,因为超过10%为肿瘤(近2%为恶性);当出血性卵巢囊肿特征典型时,专家评估可避免随访,必要时可加速额外影像检查或干预。
研究设计与样本
- 回顾性研究,同一机构连续绝经前女性经阴道盆腔超声报告,共51,305名女性中457名(0.9%)报告提示可能大出血性卵巢囊肿;366例有明确结局;由4名超声专家复核影像,评估两项内容。
诊断标准与关键数值
- 评估1:超声特征最符合卵巢出血性囊肿或子宫内膜瘤;评估2:若评估1为真,肿块除大小外符合O-RADS典型出血性卵巢囊肿标准。评估1为真者318例,结局为出血性卵巢囊肿224例(70.4%)、子宫内膜瘤89例(28.0%)、输卵管卵巢脓肿4例(1.3%)、囊腺瘤1例(0.3%);评估1为假者48例,结局为出血性卵巢囊肿1例(2.1%)、子宫内膜瘤1例(2.1%)、其他非肿瘤性囊肿6例(12.5%)、良性肿瘤33例(68.8%)、交界性肿瘤5例(10.4%)、高级别恶性肿瘤2例(4.2%);评估1为真时肿瘤和恶性肿瘤减少显著(p<.001)。评估2为真者190例(出血性卵巢囊肿180例[94.7%]、子宫内膜瘤9例[4.7%]、囊腺瘤1例[0.5%]),为假者128例(出血性卵巢囊肿44例[34.4%]、子宫内膜瘤80例[62.5%]、输卵管卵巢脓肿4例[3.1%])(p<.001),不适用者48例。
临床应用与阅片要点
- 超声专家复核标注为可能大出血性卵巢囊肿的附件肿块有附加价值,因超过10%为肿瘤(近2%为恶性);当出血性卵巢囊肿特征典型时,专家评估可避免随访,必要时可加速额外影像检查或干预。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Evaluate the value of ultrasound specialist assessment of ovarian masses over 50 mm with sonograms interpreted as possible hemorrhagic ovarian cysts (HOC).
METHODS: Retrospective review of consecutive endovaginal pelvic US reports of premenopausal women at one organization identified adnexal masses over 50 mm maximum diameter designated as possibly being HOC (large HOC). Four ultrasound specialists reviewed studies, scoring two assessments as true or false: 1) US features are most consistent with either an ovarian hemorrhagic cyst (HOC) or endometrioma; 2) If assessment 1 was true, the mass meets O-RADS criteria of classic HOC except for size.
RESULTS: A total of 457 of 51,305 women (0.9%) had reports indicating possible large HOC. For 366 patients with established outcomes, 225 (61.5%) had a large HOC (87.1% ≤ 70 mm). Assessment 1 was true for 318 patients; outcomes showed 224 (70.4%) HOC, 89 (28.0%) endometriomas, 4 (1.3%) TOAs, and 1 (0.3%) cystadenoma. Assessment 1 was false for 48 patients; outcomes showed 1 (2.1%) HOC, 1 (2.1%) endometrioma, 6 (12.5%) other non-neoplastic cysts, 33 (68.8%) benign neoplasms, 5 (10.4%) borderline tumors, and 2 (4.2%) high-grade malignancies. The decrease in neoplasms and malignancies with true assessment 1 was significant (p < .001). Assessment 2 was true for 190 patients (180 [94.7%] HOC, 9 [4.7%] endometrioma, 1 [0.5%] cystadenoma), false for 128 patients (44 [34.4%] HOC, 80 [62.5%] endometrioma, and 4 [3.1%] TOA) (p < .001), and not applicable for 48 patients.
CONCLUSIONS: Ultrasound specialist review of adnexal masses designated as a possible large HOC adds value since over 10% are neoplasms (nearly 2% malignant). Ultrasound specialist assessment can expedite additional imaging or intervention when necessary and obviate follow-up when HOC features are typical.
引用
- Zhu A, Sugi M, Young SW, et al. Hemorrhagic Ovarian Cysts Over 50 mm: Value of Ultrasound Specialist Assessment. J Ultrasound Med. 2025. PMID: 41024600. doi:10.1002/jum.70081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。